Brickell Biotech logo
Brickell Biotech BBI
$ 2.11 -5.38%

Annual report 2023
added 03-15-2024

report update icon

Brickell Biotech Financial Ratios 2011-2024 | BBI

Annual Financial Ratios Brickell Biotech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.0 -0.3 -0.0 -1.5 -0.2 -1.3 -1.5 -2.4 -3.5 -5.6 -3.8 -13.4 -35.0

P/S

1.4 0.9 0.9 16.7 0.6 13.2 1.4 1.5 1.5 6.1 15.5 17.5 8.5

EPS

-1.1 -7.5 -22.1 -0.8 -4.5 -25.9 -1.0 -0.9 -0.1 -0.2 -0.4 -0.3 -0.1

EV (Enterprise Value)

515 K -2.75 M -26.5 M 6.74 M 8.02 M 13.1 M 11.2 M 23.9 M 23.2 M 77.9 M 85.9 M 271 M 225 M

EBITDA per Share

-1.17 -7.66 -22.5 -0.746 -8.08 -6.25 -6.84 -5.63 -6.29 -11.8 -23.5 -17.5 -5.37

EV/EBITDA

0.7 -0.0 0.1 -0.7 0.5 -2.1 -2.3 -4.8 -2.8 -12.3 -39.2

PEG

-0.0 -0.0 -0.0 -0.02 -0.01 -0.05 0.12 -0.24 -0.07 -0.12 0.12 0.08 -0.44

P/B

1.0 0.6 0.0 1.1 0.6 0.4 0.3 0.5 0.7 1.8 2.0 3.4 4.2

P/CF

-2.6 -0.3 -0.0 -1.5 -0.1 -1.5 -2.2 -2.5 -4.5 -9.1 -3.9 -16.5 -56.5

ROE %

-57.34 -293.33 -158.49 -77.07 -315.25 -33.33 -20.38 -19.88 -20.35 -31.76 -50.87 -25.70 -12.07

ROA %

-49.15 -205.45 -132.83 -62.18 -131.60 -31.05 -16.10 -17.16 -18.51 -28.44 -47.08 -23.72 -10.59

ROCE %

-64.05 -299.33 -161.58 -76.89 -319.97 -40.29 -21.05 -20.33 -20.55 -31.50 -50.00 -25.82 -12.55

Current Ratio

- - - 5.3 1.7 13.7 4.5 6.7 10.7 9.9 15.9 14.9 8.3

DSO

- - - - - 253.8 135.3 224.4 79.2 100.2 217.1 44.8 38.1

DIO

- - - - - - - - - - - - -

DPO

- - - - - 104.7 68.3 18.9 24.5 7.7 11.4 - 12.5

Operating Cycle

- - - - - 253.8 135.3 224.4 79.2 100.2 217.1 - 38.1

Cash Conversion Cycle

- - - - - 149.1 67.0 205.5 54.7 92.6 205.7 - 25.6

All numbers in USD currency

Quarterly Financial Ratios Brickell Biotech

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.32 -0.39 -1.14 - -2.07 -0.43 -3.55 - -0.16 -0.16 -0.15 - -0.15 -0.43 -0.45 -1.38 -1.65 -6.49 10.08 -7.72 -5.98 -7.53 -4.63 -0.21 -0.27 -0.3 -0.25 -0.25 -0.24 -0.14 -0.26 -0.26 -0.03 -0.3 -0.04 -0.05 -0.05 -0.05 -0.04 -0.03 -0.11 -0.11 -0.11 -0.09 -0.09 -0.09 - -0.09 0.23 -0.12 -0.12

EBITDA per Share

- - -1.15 - -2.09 -0.54 -3.54 - -0.16 -0.17 -0.15 - -0.15 -0.43 -0.45 -1.28 -2.05 -5.02 -7.78 -6.11 -3.86 -0.15 0.04 - -0.21 -0.26 -0.24 - -0.17 -0.08 -0.24 - 0.06 -0.24 -0.04 - -0.03 -0.04 -0.03 - -0.09 -0.1 -0.1 - -0.07 -0.08 - - 0.25 -0.1 -0.11

ROE %

-106.33 -179.16 -157.92 -119.59 -185.96 -198.71 -241.26 -147.15 -163.09 -112.66 -81.65 -49.93 -193.34 -240.52 -269.90 -315.25 -166.71 -100.04 -59.08 2.47 3.56 -4.84 -2.78 -8.30 -20.66 -21.39 -18.95 -19.88 -18.93 -14.00 -17.30 -20.35 -24.09 -31.83 -33.53 -31.76 -26.41 -34.10 -42.41 -50.87 -55.77 -48.35 -41.09 -25.70 -28.19 7.71 2.61 -12.07 27.23 -13.93 -14.41

ROA %

-42.82 -65.14 -48.13 -57.66 -106.25 -161.05 -193.20 -116.32 -129.18 -87.25 -64.12 -40.28 -100.15 -113.63 -118.55 -131.60 -113.68 -116.37 -103.02 -76.77 -39.45 -14.25 -11.59 -16.10 -16.77 -17.76 -16.04 -17.16 -16.58 -12.35 -15.49 -18.51 -21.78 -28.71 -30.14 -28.44 -23.76 -31.13 -39.05 -47.08 -51.60 -44.71 -37.97 -23.72 -25.52 6.38 2.30 -10.59 23.89 -12.22 -12.64

ROCE %

-109.48 -181.86 -161.60 -122.08 -188.98 -201.75 -244.22 -149.59 -165.62 -114.75 -81.84 -50.03 -193.16 -257.08 -277.52 -323.05 -174.89 -91.74 -59.20 3.01 -7.02 -15.24 -13.81 -14.95 -20.65 -21.34 -18.90 -14.18 -14.92 -9.95 -13.18 -15.38 -23.85 -31.58 -33.26 -23.00 -39.25 -47.04 -55.24 -47.43 -56.17 -48.65 -41.53 -17.80 9.36 45.26 40.16 -1.29 27.16 -14.00 -14.44

Current Ratio

- - - - - - - 6.2 5.7 4.3 4.0 5.2 5.2 5.2 5.2 1.7 1.7 1.7 1.7 0.4 0.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - 37.8 - - 1120.0 3422.8 170.0 398.4 118.3 144.3 136.7 121.7 98.7 118.2 75.8 78.9 60.9 82.7 99.3 80.5 79.0 110.8 84.6 163.5 133.2 271.4 287.7 195.4 84.7 90.3 125.5 21.0 147.8 10.7 349.2 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - 37.8 - - 1120.0 3422.8 170.0 398.4 118.3 144.3 136.7 121.7 98.7 118.2 75.8 78.9 60.9 82.7 99.3 80.5 79.0 110.8 84.6 163.5 133.2 271.4 287.7 195.4 84.7 90.3 125.5 21.0 147.8 10.7 349.2 -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - 37.8 - - 1120.0 3422.8 170.0 398.4 118.3 144.3 136.7 121.7 98.7 118.2 75.8 78.9 60.9 82.7 99.3 80.5 79.0 110.8 84.6 163.5 133.2 271.4 287.7 195.4 84.7 90.3 125.5 21.0 147.8 10.7 349.2 -

All numbers in USD currency